Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)

44.97 USD  |  NASDAQ  |  Jul 31, 16:00
More

Cerevel Therapeutics Holdings Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for CERE:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade